Predictive model of antimicrobial-resistant Gram-negative bacteremia at the ED

American Journal of Emergency Medicine

Volumn 25, Issue 6, 2007, Pages 597-607

  Chiang, Wen Chu ^a   Chen, Shey Ying ^a   Chien, Kuo Liong ^b   Hui Min, Grace ^b   Ming Fang Yen, Amy ^b   Su, Chan Ping ^a   Lee, Chien Chang ^a   Chen, Yee Chun ^a   Chang, Shan Chwen ^a   Chen, Shyr Chyr ^a   Chen, Wen Jone ^a   Hsiu Hsi Chen, Tony ^b  

^a NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; CEFAZOLIN; CEFTRIAXONE; IMMUNOSUPPRESSIVE AGENT; STEROID; VANCOMYCIN;

ADULT; AGED; ARTICLE; BLOOD CULTURE; COMORBIDITY; CONTROLLED STUDY; DRUG SENSITIVITY; EMERGENCY WARD; FEMALE; GRAM NEGATIVE SEPSIS; HIGH RISK PATIENT; HOSPITALIZATION; HUMAN; LEUKOCYTE COUNT; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; MALE; MICROBIOLOGICAL EXAMINATION; OXYGEN SATURATION; PRIORITY JOURNAL; SCORING SYSTEM; STROKE;

ADULT; AGED; ANALYSIS OF VARIANCE; ANTI-INFECTIVE AGENTS; BACTEREMIA; CEPHALOSPORINS; DECISION SUPPORT TECHNIQUES; DRUG RESISTANCE, MICROBIAL; EMERGENCY SERVICE, HOSPITAL; FEMALE; GRAM-NEGATIVE BACTERIA; GRAM-NEGATIVE BACTERIAL INFECTIONS; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; RISK FACTORS; ROC CURVE;

EID: 34250874391     PISSN: 07356757     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ajem.2006.11.024     Document Type: Article

References (35)

1. Carmeli Y., Troillet N., Karchmer A.W., et al. Health and economic outcomes of antibiotic resistance in Pseudomonas aeruginosa. Arch Intern Med 159 (1999) 1127-1132
2. Lautenbach E., Patel J.B., Bilker W.B., et al. Extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae: risk factors for infection and impact of resistance on outcome. Clin Infect Dis 32 (2001) 1162-1171
3. Virk A., and Steckelberg J.M. Clinical aspects of antimicrobial resistance. Mayo Clin Proc 75 (2000) 200-214
4. Zuccotti G.V., Gracchi V., Sala D., et al. Nosocomial infections at a pediatric age. Pediatr Med Chir 24 (2002) 177-185
5. Weinstein M.P., Towns M.L., Quartey S.M., et al. The clinical significance of positive blood cultures in the 1990s: a prospective comprehensive evaluation of the microbiology, epidemiology, and outcome of bacteremia and fungemia in adults. Clin Infect Dis 21 (1997) 584-602
6. Pop-Vicas A.E., and D'Agata E.M. The rising influx of multidrug-resistant Gram-negative bacilli into a tertiary care hospital. Clin Infect Dis 40 (2005) 1792-1798
7. Lucet J.C., Chevert S., Decre D., et al. Outbreak of multiply resistant Enterobacteriaceae in an intensive care unit: epidemiology and risk factors for acquisition. Clin Infect Dis 22 (1996) 430-436
8. De Champs C., Rouby D., Guelon D., et al. A case-control study of an outbreak of infections caused by Klebsiella pneumoniae strains producing CTX-1(TEM-3) beta-lactamase. J Hosp Infect 18 (1991) 5-13
9. Paterson D.L., Mulazimoglu L., Casellas J.M., et al. Epidemiology of ciprofloxacin resistance and its relationship to extended-spectrum beta-lactamase production in Klebsiella pneumoniae isolates causing bacteremia. Clin Infect Dis 30 (2000) 437-438
10. Wiener J., Quinn J.P., Bradford P.A., et al. Multiple antibiotic-resistant Klebsiella pneumoniae and Escherichia coli in nursing home. JAMA 281 (1999) 517-523
11. Friedman N.D., Kaye K.S., Stout J.E., et al. Health care-associated bloodstream infections in adults: a reason to change the accepted definition of community-acquired infections. Ann Intern Med 137 (2002) 791-797
12. Siegman-Igra Y., Fourer B., Orni-Wasserlauf R., et al. Reappraisal of community-acquired bacteremia: a proposal of a new classification for the spectrum of acquisition of bacteremia. Clin Infect Dis 34 (2002) 1431-1439
13. Schiappa D.A., Hayden M.K., Matushek M.G., et al. Ceftazidime-resistant Klebsiella pneumoniae and Escherichia coli bloodstream infection: a case-control and molecular epidemiologic investigation. J Infect Dis 174 (1996) 529-536
14. Blot S., Vandewoude K., De Bacquer D., et al. Nosocomial bacteremia caused by antibiotic-resistant Gram-negative bacteria in critically ill patients: clinical outcome and length of hospitalization. Clin Infect Dis 34 (2002) 1600-1606
15. Pena C., Pujol M., Ricart A., et al. Risk factors for faecal carriage of Klebsiella pneumoniae producing extended spectrum beta-lactamase (ESBL-KP) in intensive care unit. J Hosp Infect 35 (1997) 9-16
16. Piroth L., Aube H., Doise J.M., et al. Spread of extended-spectrum beta-lactamase-producing Klebsiella pneumoniae: are beta-lactamase inhibitors of therapeutic value?. Clin Infect Dis 27 (1998) 76-80
17. Ho M., Hsiung C.A., Yu H.T., et al. Antimicrobial usage in ambulatory patients with respiratory infections in Taiwan, 2001. J Formos Med Assoc 103 (2004) 96-103
18. Goldberg D. The cephalosporins. Med Clin North Am 71 (1987) 1113
19. Gantz N.M., Brown R., Berk S.L., Esposito A.L., et al. Manual of clinical problems in infectious disease. Chap. 74: choosing a cephalosporin. 4th ed. (1999) 410-414
20. MacDonald K.L., Cohen M.L., Hargrett-Bean N.T., et al. Changes in antimicrobial resistance of Salmonella isolated from humans in the United States. JAMA 11 (1987) 1496-1499
21. Ackers M.L., Puhr N.D., Tauxe R.V., et al. Laboratory-based surveillance of Salmonella serotype Typhi infections in the United States: antimicrobial resistance on the rise. JAMA 283 (2000) 2668-2673
22. Ko W.C., Lee H.C., Chuang Y.C., et al. Clinical features and therapeutic implications of 104 episodes of monomicrobial Aeromonas bacteraemia. J Infect 40 (2000) 267-273
23. Weber J.T., Mintz E.D., Canizares R., et al. Epidemic cholera in Ecuador: multidrug-resistance and transmission by water and seafood. Epidemiol Infect 112 (1994) 1-11
24. van den Bogaard A.E., and Stobberingh E.E. Antibiotic usage in animals: impact on bacterial resistance and public health. Drugs 58 (1999) 589-607
25. Sharma H., Unicomb L., Forbes W., et al. Antibiotic resistance in Campylobacter jejuni isolated from humans in the Hunter Region, New South Wales. Commun Dis Intell 27 Suppl (2003) S80-S88
26. Hanley J.A., and McNeil B.J. The meaning and use of the area under a receiver operating characteristic (ROC) curve. Radiology 143 (1982) 29-36
27. Wasson J.H., Sox H.C., Neff R.K., et al. Clinical prediction rules. Applications and methodological standards. N Engl J Med 313 (1985) 793-799
28. Laupacis A., Sekar N., and Stiell I.G. Clinical prediction rules. A review and suggested modifications of methodological standards. JAMA 277 (1997) 488-494
29. Sullivan L.M., Massaro J.M., and D'Agostino Sr. R.B. Presentation of multivariate data for clinical use: The Framingham Study risk score functions. Stat Med 23 (2004) 1631-1660
30. Jaimes F., Arongo C., Ruiz G., et al. Predicting bacteremia at the bedside. Clin Infect Dis 38 (2004) 357-362
31. Aloy Duch A., Espejo Arenas E., Mauri Pont M., et al. Bacteremia in the patient with liver cirrhosis. Prospective study of 61 episodes. Enferm Infecc Microbiol Clin 8 (1990) 540-543
32. Kuo C.H., Changchien C.S., Yang C.Y., et al. Bacteremia in patients with cirrhosis of the liver. Liver 11 (1991) 334-339
33. Mizuno R., Nishiyama Y., Shimizu S., et al. Clinical study on bacteremia in patients with liver cirrhosis. Kansenshogaku Zasshi 70 (1996) 456-462
34. Thulstrup A.M., Sorensen H.T., Schonheyder H.C., et al. Population-based study of the risk and short-term prognosis for bacteremia in patients with liver cirrhosis. Clin Infect Dis 31 (2000) 1357-1361
35. Graudal N., Milman N., Kirkegaard E., et al. Bacteremia in cirrhosis of the liver. Liver 6 (1986) 297-301